New Treatment of Aortic Stenosis by Transcatheter Aortic Valve Research Paper

New Treatment of Aortic stenosis by Transcatheter Aortic Valve Implantation - research Paper ExampleThe most common of aortic stricture undergo in patients 65 years of age and over (called senile calcific aortic stenosis) (Kulick, 2012). General symptom of aortic stenosis patients ar exertional dyspnea (shorten fatigue), angina pectoris (chest pain), syncopy (fainting), and congestive heart failure. Every aortic stenosis patient will be investigated by multidisciplinary team 2 interventional cardiologists, 1 cardiac surgeon, and an anaesthesiologist (Bedogni et al., 2011). In general, the treatment for aortic stenosis patients, who are not showing symptoms of the disease, is to take medicine while the severely symptomatic aortic stenosis patients mustiness have surgical aortic valve replacement. Transcatheter aortic valve implantation (TAVI) is the new procedure for severe aortic stenosis treatment. The progression of this treatment makes it suitable for patients who are inoper able or very amply risk with step surgical aortic valve replacement. In addition, the procedure of TAVI is executed in a catheterization laboratory or intercrossed operating room, under general anaesthesia and without cardiopulmonary bypass (Jean-Bernard et al., 2009). The procedure of TAVI is the device implant with twain transcatheter aortic valves (the Edwards SAPIEN valve, ESV or the Medtronic Corevalve, MCV) with three approaches used (transfemoral, transaxillary, or transapical) (Godino et al., 2010). The transcatheter aortic valve implantation (TAVI) was underwent with the first patient in 2002 (Rodes-Cabau, 2010). Furthermore, TAVI clearly achieved safety and efficacy of the percutaneous treatment in aortic stenosis towards the end of 2010 (success judge 90% and 30 days procedural mortality rates 10%) (Rodes-Cabau, 2010). The aim of this case conceive will be to capture the progression of transcatheter aortic valve implantation, for patients who are inoperable or wit h very high surgical risk in standard aortic valve replacement. Firstly, it will briefly review the cause of aortic stenosis, followed by an explanation of transcatheter aortic valve implantation procedure with two diversion transcatheter aortic valves and three difference approaches. Finally, the major effective procedure of TAVI and future development of TAVI will be discussed. Impact of Aortic stricture Degenerative Aortic Stenosis is the most common valve disease, and its prevalence is projected to increase in the sexual climax years due to aging populations. This has implications not only for those specializing in cardiovascular disease Aortic Stenosis is change magnitudely diagnosed and treated by other medical specialties, including internal medicine, geriatrics and intensive care. This point to the increasing rang of the impacts that aortic Stenosis has been established to have. The Aorta, both ascending and descending, is responsible for the circulation of oxygenates blo od throughout the body. It is no honor that the partial or complete Stenosis of the Aorta would lead to varied conditions that can be detected any in Intensive care Unit, when the patient is in a stupor, or by the gastric, as a result of ventral pooling of blood, caused by its stagnation in the veins, venules, and arterioles. This pooling is caused by the lack of, or limited blackjack from the Aorta, to help in the circulation of